Skip to main content

Currently Skimming:

Forum on Neuroscience and Nervous System Disorders: 2011 Annual Report
Pages 1-12

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 1...
... BOARD ON HEALTH SCIENCES POLICY Forum on Neuroscience and Nervous System Disorders 2011 Annual Report
From page 2...
... Cover Image Credits Left: Greg Hood, John Burkardt, and Greg Foss, Pittsburgh Supercomputing Center Right: Paul Thompson and Arthur Toga, UCLA
From page 3...
... Discussions in 2011 focused on a diverse array of topics, including the implications of recent cutbacks by major pharmaceutical companies in drug development for central nervous system disorders, and how to better coordinate and facilitate research across the various stakeholders that make up the neuroscience community. With an agenda set by the members, the Forum undertook a variety of initiatives to address these challenges and opportunities.
From page 4...
... These regulations are intended to ensure that animals in research receive humane care and use and that practical steps are taken to use the smallest number of animals to give significant results while ensuring that each individual animal experiences minimum pain or distress. The goal of the workshop was to bring together researchers, legal scholars, administrators, and other key stakeholders to discuss current trends and cross-national differences in animal regulations.
From page 5...
... This forum series was launched in 2008 as a venue where scientific conferences and meetings could be held to "help the scientific leadership of the United Kingdom and the United States forge an enduring and productive partnership on pressing topics of worldwide scientific concern with benefit to all people." The meeting drew on the convening power of the sponsoring organizations to bring together experts for presentations and moderated discussions in the following topic areas: neuroscience in court; mind reading (to include a discussion of lie detection, pain, and false memory) ; criminal responsibility and sentencing; moral reasoning and psychopathy; and the developing brain.
From page 6...
... The workshop will explore commonalities across neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal dementia, and identify potential opportunities for collaboration across the respective research and development communities. Participants will be invited from academia; pharmaceutical and biotechnology industries; government agencies such as the NIH, National Science Foundation, and Veterans Administration; and patient advocacy groups.
From page 7...
... Critical to this effort includes increasing the number of health care workers with expertise in MNS disorders, strengthening medical neuroscience education systems, and build ing clinical and research neuroscience capacity in African medical schools and clini cal training programs for nurses, medical officers, and primary care workers. The Forum, in collaboration with the World Health Organization (WHO)
From page 8...
... A working group will be established to examine current practices of training scientists and identify opportunities for increasing and strengthening translational neuroscience programs. Jun 17 Aug 4–5 Nov 9 Jun 22 9th meeting Sub-Saharan Africa Workshop Animal Law Workshop Glutamate Workshop 2010 Jun 16 Nov 3 Mar 8–9 Suicidality Workshop 10th meeting Sex Differences Workshop
From page 9...
... Mar 2–3 Jul 12 Neuroscience and ADNI-2 Workshop the Law Workshop 2011 Jun 23 Dec 10 Feb 2 11th meeting 12th meeting 13th meeting
From page 10...
... Daniel Javitt Marc Tessier-Lavigne American Association for the New York University School of The Rockefeller University Advancement of Science Medicine William Thies Huda Akil Story Landis Alzheimer's Association University of Michigan National Institute of Neurological Nora Volkow Disorders and Stroke National Institute on Drug Abuse Marc Barlow GE Healthcare Husseini Manji Kenneth Warren Johnson & Johnson Pharmaceuticals National Institute on Alcohol Mark Bear Massachusetts Institute David Michelson Abuse and Alcoholism of Technology Merck & Co., Inc. Doug Williamson Daniel Burch Jonathan Moreno Lilly Research Laboratories CeNeRx Biopharma University of Pennsylvania School John Wingfield of Medicine National Science Foundation Timothy Coetzee FastForward of the National Kathie Olsen Frank Yocca Multiple Sclerosis Society Association of Public and AstraZeneca Pharmaceuticals Land-Grant Universities David Cohen Stevin Zorn Columbia University, Society Alexander Ommaya Lundbeck USA for Neuroscience representative Department of Veterans Affairs Charles Zorumski John Dunlop Atul Pande Washington University, St.
From page 11...
... Fox Foundation for Parkinson's Research National Eye Institute National Institute of Mental Health Industry National Institute of Neurological Disorders and Stroke National Institute on Aging National Institute on Alcohol Abuse and Alcoholism National Institute on Drug Abuse National Institutes of Health Blueprint for Neuroscience Research National Multiple Sclerosis Society National Science Foundation Pfizer Society for Neuroscience Jul 11 17th meeting May 10–11 Sep 3–6 Nov 28 Neurodegeneration Workshop SSA Workforce Workshop 18th meeting
From page 12...
... The Institute of Medicine serves as adviser to the nation to improve health. Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public.


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.